Roles of Oxidative Stress in Policystic Ovary Syndrome
References
- 1. Hoffman B.L., Shorge O.J, Bradshaw D.K., Halvorson M.L., Schaffer I.J., Corton M.M. (2016.) Williams Gyneclogy (3th ed), New York, USA: Mc Graw Hill Education.
- 2. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction.2004; 19(1): 41–47.
- 3. Al-Gugory KH, Fowler PA, Garrel C. The role of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcome. Int J Biochem. 2010; 42: 1634-50.
- 4. Burton G.J., Jauniaux E. Oxidative stress. Best Pract. Res. Clin. Obstet. Gynaecol. 2011; 25(3): 287-99.
- 5. Agarwal A, Saleh RA, Bedaiwy MA: Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril. 2003; 79: 829-843.
- 6. Bellver J, Melo MA, Bosch E, Sewa V, Remotin J, Pellier A. Obesity and poor reproductive outcome; the potential role of the endometrium. Fertil Steril. 2007; 88(2): 446-51.
- 7. Zhao Y, Zhang C, Huang Y, Yu Y, Li R, Li M, et al. Upregulated expression of WNT5a increases inflammation and oxidative stress via PI3K/AKT/NF-kB signaling in the granulosa cells of PCOS patients. J Clin Endocrinol Metab. 2015; 100: 201–11.
- 8. Escobar-Morreale, H.F., Luque-Ramírez, M., González, F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril. 2011; 95:1048–58.
- 9. Gonzalez F, Rote NS, Minium J, Kirwan JP. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006; 91: 336–40.
- 10. Victor VM, Rocha M, Bañuls C, Sanchez-Serrano M, Sola E, Gomez M, et al. Mitochondrial complex I impairment in leukocytes from polycystic ovary syndrome patients with insulin resistance. J Clin Endocrinol Metab. 2009; 94: 3505–12.
- 11. Victor VM, Rocha M, Bañuls C, Alvarez A, de Pablo C, Sanchez-Serrano M, et al. Induction of oxidative stress and human leukocyte/endothelial cell interactions in polycystic ovary syndrome patients with insulin resistance. J Clin Endocrinol Metab. 2011; 96: 3115–22.
- 12. Gonzalez F, Rote NS, Minium J, Kirwan JP. In vitro evidence that hyperglycemia stimulates tumor necrosis factor alpha release in obese women with polycystic ovary syndrome. J Endocrinol. 2006; 188: 521–29.
- 13. Orio F Jr, Palomba S, Cascella T, Di Biase S, Manguso F, Tauchmanovà L, et al. The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. J Clin Endocrinol Metab. 2005; 90: 2–5.
- 14. Miyamoto K, Sato EF, Kasahare E, Jikumaru M, Hiramoto K, Tabate H, et al. Effect of oxidative stress during repeated ovulation on the structure and function of the ovary, oocyte and the mitochondria. Free Radical Biol Med. 2010; 49(4): 674-81
- 15. Mohammadi M. Oxidative Stress and Polycystic Ovary Syndrome: A Brief Review.Int J Prev Med. 2019; 10: 86.
- 16. Özer A, Bakacak M, Kıran H, Ercan Ö, Köstü B. Increased oxidative stress is associated with insulin resistance and infertility in policistic ovarian sindrome. Ginekologia Polska. 2016; 87(11): 733–38.
- 17. Panti A, Shehu C, Saidu Y, et al. Oxidative stress and outcome of antioxidant supplementation in patients with polycystic ovarian syndrome (PCOS). Int J Reprod Contracept Obstet Gynecol. 2018; 7: 1667–72.
- 18. Victor VM, Rovira-Llopis S, Bañuls C, DiazMorales N, Martinez de Marañon A, Rios-Navarro C, et al. Insulin Resistance in PCOS Patients Enhances Oxidative Stress and Leukocyte Adhesion: Role of Myeloperoxidase. PLoS One.2016; 11(3): e015-1960.
- 19. Gyftaki R, Gougoura S, Kalogeris N, Loi V, Koukoulis G, Vryonidou A. Oxidative stress markers in women with polycystic ovary syndrome without insulin resistance. Endocrine Abstracts. 2018; 56: 950.
- 20. Uyanikoglu H, Icon O, Sabuncu T, Dursun H, Sezen h & Aksoy N, Circulating levels of apoptotic markers and oxidative stress parameters in women with polycystic ovary syndrome: a case-controlled descriptive study. Journal Biomarkers. 2017; 22(7): 643-47.
- 21. Deepika M.L.N, K Nalini S, Maruthi G,Ramchander V, Ranjith K, Latha P, Usha Rani V. and Jahan P. Analysis of Oxidative Stress Status Through MN Test and Serum MDA Levels in PCOS Women. Pakistan Journal of Biological Sciences. 2014; 17: 574-77.
- 22. Chen L, Ming Xu W, Zhang D, Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome. Fertility and Sterility. 2014; 102(4): 1167-74.
- 23. Kim E-J, Jang M, Choi JH, Park KS and Cho I-H. An Improved Dehydroepiandrosterone-Induced Rat Model of Polycystic Ovary Syndrome (PCOS): Post-pubertal Improve PCOS’s Features. Front. Endocrinol. 2018; 9: 735.
- 24. Wang Y. et al.: Eicosapentaenoic acid improves polycystic ovary syndrome. Med Sci Monit. 2018; 24: 2091-97.
- 25. Sanaz Alivandi F, Khazali H. Therapeutic effects of isoflavone-aglycone fraction from soybean (Glycinemax L. Merrill) in rats with estradiol valerateinduced polycystic ovary syndrome as an inflammatory state. Gynecological Endocrinology.2019;35(12):1078-83.
- 26. Çelik L.S, Kuyucu Y, Yenilmez E.D, Tuli A, Dağlıoğlu K& Özgü M. U. Effects of vitamin D on ovary in DHEAtreated PCOS rat model: A light and electron microscopic stud. Ultrastructural Pathology.2017;42(6): 55-64.
DOI: https://doi.org/10.2478/sjecr-2019-0059 | Journal eISSN: 2956-2090 (formerly 2335-075X, 2956-0454) | Journal ISSN: 2956-0454 (formerly 1820-8665)
Language: English
Submitted on: Oct 10, 2019
Accepted on: Nov 4, 2019
Published on: Dec 11, 2019
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2019 Marija Bicanin Ilic, Aleksandra Dimitrijevic, Igor Ilic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.